| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,846 |
15,480 |
$377K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
9,186 |
8,816 |
$228K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,918 |
9,905 |
$196K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,217 |
6,168 |
$194K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,611 |
5,006 |
$145K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
11,552 |
8,641 |
$102K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
897 |
884 |
$94K |
| 99051 |
|
8,789 |
7,743 |
$50K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,336 |
5,231 |
$34K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,381 |
2,237 |
$17K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
911 |
813 |
$17K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
485 |
479 |
$12K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,626 |
1,550 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,227 |
2,167 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,875 |
921 |
$8K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,298 |
1,165 |
$6K |
| 81003 |
|
2,264 |
2,087 |
$5K |
| 99001 |
|
922 |
866 |
$4K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
110 |
99 |
$2K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
80 |
79 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
175 |
158 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
91 |
90 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
165 |
156 |
$897.33 |
| A9150 |
Non-prescription drugs |
418 |
414 |
$724.20 |
| 73610 |
|
58 |
58 |
$686.11 |
| 99000 |
|
731 |
695 |
$666.56 |
| 87807 |
|
134 |
133 |
$565.69 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
52 |
52 |
$468.78 |
| 73630 |
|
31 |
31 |
$449.78 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
100 |
96 |
$447.28 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
76 |
76 |
$242.98 |
| 29540 |
|
23 |
23 |
$223.49 |
| 73130 |
|
12 |
12 |
$170.46 |
| 93000 |
|
12 |
12 |
$155.53 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
201 |
198 |
$87.98 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
18 |
12 |
$85.00 |
| 82962 |
|
15 |
15 |
$85.00 |
| 81025 |
|
29 |
29 |
$52.88 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
26 |
26 |
$46.59 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
16 |
16 |
$31.50 |
| 99173 |
|
12 |
12 |
$24.18 |
| 73562 |
|
16 |
15 |
$23.38 |
| A6448 |
Light compression bandage, elastic, knitted/woven, width less than three inches, per yard |
14 |
14 |
$3.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
39 |
39 |
$0.00 |